PubMed Health⌕ Search

Biomedical subjects

A M Pope

Publications and source records attributed to A M Pope.

14 recordsLinked to original sources
PubMed1992

Preventing secondary conditions.

A secondary condition is any additional physical or mental health condition that is causally related to a primary disabling condition. Secondary conditions often increase the severity of an individual's disability and are highly preventable. The Institute of Medicine model of the disabling process, including risk factors, quality of life, and secondary conditions is presented along with a discussion of the components of a comprehensive disability prevention program.

Adolescent↗
PubMed1991

2-Chloro-1-(2,4-dichlorophenyl)-3-(1H-imidazol-1-yl)-2-phenylpropan-1-one hydrochloride, a novel, nonmutagenic antibacterial with specific activity against anaerobic bacteria.

1-(2,4-Dichlorophenyl)-2-phenylpropen-1-one (2) is identified as a potent antibacterial agent. A compound, 2-chloro-1-(2,4-dichlorophenyl)-3-(1H-imidazol-1-yl)-2-phenylpropan++ +-1-one (5) has been designed with the intention of its acting as a pro-drug, liberating the lethal species 2 specifically within the target anaerobic bacterial cell following bioreduction by bacterial ferredoxin or related electron transfer proteins. The synthesis and biological activity of 5 is described and compared with the activities of the analogous alpha-bromo ketone 6 and alpha-fluoro ketone 7. Synthesis of 6, 7, and the corresponding alpha-hydroxy ketone 11 is also described.

Alkenes↗
PubMed1986

Trichlorfon-induced congenital cerebellar hypoplasia in neonatal pigs.

The neuroteratogenicity of trichlorfon was evaluated in 3 groups of pregnant sows (8/group). The treatments were: control (no trichlorfon), trichlorfon (60 mg/kg of body weight) in the feed only on day 55 of gestation, or trichlorfon (60 mg/kg of body weight) in the feed on day 55 and day 70 of gestation. One week after farrowing, all newborn pigs were removed from the sows and were euthanatized. Brain and cerebellum weights of the newborn pigs were recorded. Mean cerebellum weights and cerebellum/total brain weight ratios of the neonatal pigs were 3.780 and 0.106 (group 1, n = 26), 3.183 and 0.098 (group 2, n = 42), and 2.986 and 0.088 (group 3, n = 61). Although trichlorfon interfered with cerebellar development and the severity of the trichlorfon-induced cerebellar hypoplasia was dosage-related, ataxia did not develop in the neonatal pigs.

Animals↗
PubMed1985

Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.

A mixture of enzymes (mycolase) capable of lysing yeast cell walls was prepared from culture filtrates of Physarum polycephalum. The enzymes present in mycolase included chitinase, beta-1,3-glucanases and exo-glycosidases. The pH optima of these enzymes were in the range 3.5-5.0 and they had low activities at pH 7.0. Mycolase produced spheroplasts from Candida pseudotropicalis and, unlike commercial enzyme preparations such as L1, chitinase, beta, 1,3-glucanase and beta-glucosidase, had some candicidal activity in vitro against C. pseudotropicalis and C. albicans. Mycolase potentiated the antifungal activity of amphotericin B against C. pseudotropicalis grown in shake flask culture but did not potentiate the antifungal activity of the antibiotic against similar cultures of C. albicans; indeed antagonism between mycolase and amphotericin B was sometimes observed with the latter yeast. Mycolase caused an approximately two-fold increase in the total and viable counts of cultures of C. albicans inoculated with stationary phase cells. These increases, which were observed within about 30 min, were attributed to mycolase inducing the premature release of viable buds from 'lag' phase cells. Mycolase also increased the rate at which C. albicans formed germ tubes when the yeast was cultured in a medium containing serum. Mycolase alone or in combination with amphotericin B did not appreciably enhance phagocytosis or intracellular killing of the yeasts by unstimulated mouse peritoneal macrophages. Studies on mice infected systemically with C. albicans showed that mycolase only slightly enhanced amphotericin B therapy.

Amphotericin B↗
PubMed1983

Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent.

The preparation, determination of isomeric configuration, and antifungal properties of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride (1) are described. In vitro, compound 1 has been shown to have activity against Candida albicans comparable with miconazole. When administered orally to animals with experimentally induced vaginal candidiasis or systemic candidiasis, compound 1 produced results approaching those produced by ketoconazole. In addition, topical administration of compound 1 to rats with vaginal candidiasis produced results comparable with those produced by similar administration of clotrimazole. Unlike ketoconazole, which is active by a mechanism that is essentially fungistatic, compound 1 shares with miconazole a mode of action that is fungicidal. However, unlike miconazole, compound 1 exhibits activity following oral administration. Compound 1 has been found to be negative in the Ames test.

Animals↗
PubMed1983

Haloxon-induced delayed neurotoxicity: effect of plasma A (aryl) esterase activity on severity of lesions in sheep.

A markedly different response to the delayed neurotoxic effects of a single dose of 400 or 800 mg/kg of the organophosphorus anthelmintic haloxon was observed in two populations of sheep. Animals with a gentically determined low level of activity of the plasma enzyme A (aryl) esterase developed clinical signs of delayed neurotoxicity within one month. Lesions relating to degeneration of myelinated nerve fibers were seen in brain stem, spinal cord, and on occasion peripheral nerve. The incidence of clinical signs, and severity of lesions as determined by semiquantitative morphological study of the spinal cord, were greater in animals given the higher dose. Neither clinical signs nor lesions relating to organophosphate-induced delayed neurotoxicity were seen in sheep with high plasma activity of A esterase.

Animals↗
PubMed1979

The influence of carbohydrases on the growth of fungal pathogens in vitro and in vivo.

Mixtures of mycolytic enzymes from various sources release protoplasts from living fungal tissue under suitable conditions. Such enzyme mixtures obtained from Coprinus comatus (mycolase I), Physarum polycephalum (mycolase II) and Lycoperdon pyriforme (mycolase III) are of low toxicity in mammals when given parenterally and are able to cure experimental systemic fungal infections in mice when administered alone or in conjunction with normally ineffective levels of conventional antimycotic drugs such as amphotericin B. The effect is believed to be due to enzymic degradation of the fungal cell wall either killing the fungus directly or enhancing activity of existing antifungal agents by increasing access to the cell interior.

Amphotericin B↗
PubMed1979

Endometrial histology and post-partum mares treated with progesterone and synthetic GnRH (AY-24,031).

Foal heat was significantly delayed in 15 Thoroughbred and Quarter-horse mares by 200 mg progesterone in oil from Days 5--14 post partum. Nine of these mares subsequently received daily i.v. injections of 2 mg of a synthetic GnRH preparation (AY-24,031) from Day 2 of the progesterone-delayed oestrus but this treatment did not significantly shorten oestrus or hasten ovulation. Uterine biopsies taken on Day 15 post partum from all the mares showed a mixed endometrial morphology having both oestrous and dioestrous characteristics. There was an increased proliferation of endometrial glands in these animals at the time of ovulation compared to control mares having a normal foal heat.

Animals↗